Interim report
Page 1
Sl . No. 1 2 SYNGENE INTERNATIONAL LIMITED CIN : L85110KA1993PLC014937 Website : www.syngeneintl.com Registered office : Biocon SEZ , Biocon Park , Plot No. 2 & 3 , Bommasandra Industrial Area IV Phase , Jigani Link Road , Bommasandra , Bangalore - 560099 STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30 SEPTEMBER 2021 Particulars 3 months ended 30 September 2021 Preceding 3 months ended 30 June 2021 ( Unaudited ) ( Unaudited ) Corresponding 3 months ended in the previous year 30 September 2020 ( Unaudited ) Year to date figures for the current period ended 30 September 2021 ( Unaudited ) ( Rs . in million , except per share data ) Year to date figures Previous year for the previous period ended ended 30 September 2020 ( Unaudited ) 31 March 2021 ( Audited ) Income a ) Revenue from operations b ) Other Income Total Income Expenses a ) Cost of chemicals , reagents and consumables consumed 6,095 5.937 129 123 5,170 138 12,032 252 9,372 291 21,794 6,224 6,060 5,308 12,284 9,663 646 22,440 3 Profit before tax and exceptional item ( 1-2 ) 4 5 Profit before tax ( 3-4 ) 6 Tax expense # [ refer note 3 ] 7 Profit for the period / year ( 5-6 ) 1,836 2,064 1,313 3,900 2,240 5.517 b ) Changes in inventories of finished goods and work - in - progress ( 161 ) ( 118 ) ( 37 ) ( 279 ) ( 67 ) ( 252 ) c ) Employee benefits expense 1,794 1,679 1,562 3,473 2,927 6,415 d ) Finance costs 12 79 66 91 140 277 e ) Depreciation and amortisation expense 762 747 687 1,509 1,348 2,745 f ) Other expenses 959 822 850 1,781 1,515 3,585 g ) Foreign exchange fluctuation ( gain ) / loss , net ( 104 ) ( 154 ) ( 68 ) ( 258 ) ( 35 ) ( 171 ) Total expenses 5,098 5,119 4,373 10,217 8,068 18,116 1,126 941 935 2,067 1,595 4,324 Exceptional item [ refer note 3 and 4 ] 307 - 307 ( 350 ) 819 941 935 1,760 1,595 4,674 154 172 99 326 181 637 665 769 836 1,434 1,414 4,037 8 Other comprehensive income ( A ) ( i ) Items that will not be reclassified to profit or loss ( 4 ) ( 4 ) 6 ( 8 ) 12 ( 30 ) ( ii ) Income tax relating to items that will not be reclassified to profit or loss 1 1 ( 1 ) 2 ( 2 ) 5 ( B ) ( i ) Items that will be reclassified to profit or loss 453 ( 177 ) 1,139 276 1,507 2,375 ( ii ) Income tax relating to items that will be reclassified to profit or loss ( 134 ) 26 ( 214 ) ( 108 ) ( 314 ) ( 444 ) Other comprehensive income for the period / year , net of taxes 316 ( 154 ) 930 162 1,203 1,906 9 Total comprehensive income for the period / year ( 7 + 8 ) 981 10 Paid - up equity share capital ( Face value of Rs . 10 each ) [ refer note 7 ] 4,008 615 4,008 1,766 1,596 2,617 5,943 4,000 4,008 4,000 4,000 11 Reserves excluding revaluation reserves as per balance sheet i.e. ' Other Equity ' 24,183 12 Earnings per share ( of Rs.10 each ) ( not annualised ) ( not annualised ) ( not annualised ) ( not annualised ) ( not annualised ) ( annualised ) a ) Basic 1.64 b ) Diluted 1.63 1.90 1.88 2.10 2.09 3.53 3.51 3.56 10.15 3.54 10.08 #Includes credit for reversal of tax provision for earlier years amounting to Rs . 73 million for the quarter and half year ended 30 September 2020 and Rs . 105 million for the year ended 31 March 2021 . See accompanying notes to the financial results